Skip to main content

Advertisement

SpringerLink
Log in

ASO Visual Abstract: Survival Benefit of Chemotherapy According to 21-Gene Recurrence Score in Young Women with Breast Cancer

  • Aso Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Department of Surgery, Duke University Medical Center, Durham, NC, USA

    A. L. Nash MD, J. K. Plichta MD, MS, L. H. Rosenberger MD, MS, A. M. B. van den Bruele MD, M. L. DiNome MD, K. Westbrook MD & E. Shelley Hwang MD, MPH

  2. Duke Cancer Institute, Duke University, Durham, NC, USA

    J. K. Plichta MD, MS, L. H. Rosenberger MD, MS, A. M. B. van den Bruele MD, M. L. DiNome MD, K. Westbrook MD & E. Shelley Hwang MD, MPH

  3. Duke Cancer Institute, Biostatistics Shared Resources, Durham, NC, USA

    Y. Ren MS

Authors
  1. A. L. Nash MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. Ren MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. K. Plichta MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. H. Rosenberger MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. M. B. van den Bruele MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. L. DiNome MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K. Westbrook MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E. Shelley Hwang MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Shelley Hwang MD, MPH.

Ethics declarations

Disclosure

E. Shelley Hwang is a consultant for Merck and Astra Zeneca and is on the Scientific Advisory Board for Clinetic.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nash, A.L., Ren, Y., Plichta, J.K. et al. ASO Visual Abstract: Survival Benefit of Chemotherapy According to 21-Gene Recurrence Score in Young Women with Breast Cancer. Ann Surg Oncol 30, 2140–2141 (2023). https://doi.org/10.1245/s10434-022-12885-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12885-3

Search

Navigation